{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:32:40Z","timestamp":1793424760869,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10067-026-08375-6","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:26:14Z","timestamp":1788567974000},"page":"7039-7050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chloroquine and hydroxychloroquine retinopathy in a cohort with rheumatic diseases in Mexico: prevalence, risk factors, and retinopathy patterns"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-5924","authenticated-orcid":false,"given":"Karim","family":"Mohamed-Noriega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-5356","authenticated-orcid":false,"given":"Janett L.","family":"Riega-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8511-0640","authenticated-orcid":false,"given":"Eduardo Alejandro","family":"Trevi\u00f1o-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2639-2283","authenticated-orcid":false,"given":"Karina","family":"Palomo-Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8936-5940","authenticated-orcid":false,"given":"Jesus Hern\u00e1n","family":"Gonz\u00e1lez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3305-4465","authenticated-orcid":false,"given":"Abraham","family":"Olvera-Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4234-7083","authenticated-orcid":false,"given":"Jibran","family":"Mohamed-Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-3532","authenticated-orcid":false,"given":"Sergio Ayala-de","family":"la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3124-0395","authenticated-orcid":false,"given":"Jorge A.","family":"Esquivel-Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4836-6330","authenticated-orcid":false,"given":"Fernando","family":"Morales-Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-2109","authenticated-orcid":false,"given":"Dionicio \u00c1ngel","family":"Galarza-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-218X","authenticated-orcid":false,"given":"Jesus","family":"Mohamed-Hamsho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"8375_CR1","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/EYE.2016.298","volume":"31","author":"IH Yusuf","year":"2017","unstructured":"Yusuf IH, Sharma S, Luqmani R, Downes SM (2017) Hydroxychloroquine retinopathy. Eye (Lond) 31:828\u2013845. https:\/\/doi.org\/10.1038\/EYE.2016.298","journal-title":"Eye (Lond)"},{"key":"8375_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16:155\u2013166. https:\/\/doi.org\/10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"key":"8375_CR3","doi-asserted-by":"publisher","first-page":"1196783","DOI":"10.3389\/FPHAR.2023.1196783\/BIBTEX","volume":"14","author":"IH Yusuf","year":"2023","unstructured":"Yusuf IH, Charbel Issa P, Ahn SJ (2023) Hydroxychloroquine-induced retinal toxicity Front Pharmacol 14:1196783. https:\/\/doi.org\/10.3389\/FPHAR.2023.1196783\/BIBTEX","journal-title":"Hydroxychloroquine-induced retinal toxicity Front Pharmacol"},{"key":"8375_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0041-008X(67)90089-0","volume":"10","author":"EW McChesney","year":"1967","unstructured":"McChesney EW, Banks WF, Fabian RJ (1967) Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat. Toxicol Appl Pharmacol 10:501\u2013513. https:\/\/doi.org\/10.1016\/0041-008X(67)90089-0","journal-title":"Toxicol Appl Pharmacol"},{"key":"8375_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TYY et al (2016) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 123:1386\u20131394. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.058","journal-title":"Ophthalmology"},{"key":"8375_CR6","first-page":"1532","volume":"35","author":"IH Yusuf","year":"2021","unstructured":"Yusuf IH, Foot B, Lotery AJ (2021) The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary. Eye (Basingstoke) 35:1532\u20131537","journal-title":"Eye (Basingstoke)"},{"key":"8375_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/LUPUS-2022-000789","author":"CC Almeida-Brasil","year":"2022","unstructured":"Almeida-Brasil CC, Hanly JG, Urowitz M et al (2022) Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine. Lupus Sci Med. https:\/\/doi.org\/10.1136\/LUPUS-2022-000789","journal-title":"Lupus Sci Med"},{"key":"8375_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1191\/0961203304lu514oa","volume":"13","author":"R Araiza-Casillas","year":"2004","unstructured":"Araiza-Casillas R, C\u00e1rdenas F, Morales Y, Cardiel MH (2004) Factors associated with chloroquine-induced retinopathy in rheumatic diseases. Lupus 13:119\u2013124. https:\/\/doi.org\/10.1191\/0961203304lu514oa","journal-title":"Lupus"},{"key":"8375_CR9","doi-asserted-by":"publisher","DOI":"10.5867\/medwave.2016.05.6471","volume":"16","author":"M Garza-Leon","year":"2016","unstructured":"Garza-Leon M, Flores-Alvarado DE, Mu\u00f1oz-Bravo JM (2016) Retinal toxicity induced by antimalarial drugs: literature review and case report. Medwave 16:e6471. https:\/\/doi.org\/10.5867\/medwave.2016.05.6471","journal-title":"Medwave"},{"key":"8375_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ophtha.2014.07.018","volume":"122","author":"RB Melles","year":"2015","unstructured":"Melles RB, Marmor MF (2015) Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology 122:110\u2013116. https:\/\/doi.org\/10.1016\/j.ophtha.2014.07.018","journal-title":"Ophthalmology"},{"issue":"5","key":"8375_CR11","doi-asserted-by":"publisher","first-page":"e2410677","DOI":"10.1001\/jamanetworkopen.2024.10677","volume":"7","author":"AM Jorge","year":"2024","unstructured":"Jorge AM, Melles RB, Marmor MF et al (2024) Risk factors for hydroxychloroquine retinopathy and its subtypes. JAMA Netw Open 7:e2410677. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.10677","journal-title":"JAMA Netw Open"},{"key":"8375_CR12","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/S41433-018-0136-X","volume":"32","author":"IH Yusuf","year":"2018","unstructured":"Yusuf IH, Foot B, Galloway J et al (2018) The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary. Eye (Lond) 32:1168\u20131173. https:\/\/doi.org\/10.1038\/S41433-018-0136-X","journal-title":"Eye (Lond)"},{"key":"8375_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/JAMAOPHTHALMOL.2014.1099","volume":"132","author":"MF Marmor","year":"2014","unstructured":"Marmor MF, Hu J (2014) Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol 132:1105\u20131112. https:\/\/doi.org\/10.1001\/JAMAOPHTHALMOL.2014.1099","journal-title":"JAMA Ophthalmol"},{"key":"8375_CR14","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.1047","volume":"21","author":"G Heinze","year":"2002","unstructured":"Heinze G, Schemper M (2002) A solution to the problem of separation in logistic regression. Stat Med 21:2409\u20132419. https:\/\/doi.org\/10.1002\/sim.1047","journal-title":"Stat Med"},{"key":"8375_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(59)90604-X","volume":"2","author":"HE Hobbs","year":"1959","unstructured":"Hobbs HE, Sorsby A, Freedman A (1959) Retinopathy following chloroquine therapy. Lancet 2:478\u2013480. https:\/\/doi.org\/10.1016\/S0140-6736(59)90604-X","journal-title":"Lancet"},{"key":"8375_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/J.RDC.2019.04.008","volume":"45","author":"S Schwartzman","year":"2019","unstructured":"Schwartzman S, Samson CM (2019) Are the current recommendations for chloroquine and hydroxychloroquine screening appropriate? Rheum Dis Clin North Am 45:359\u2013367. https:\/\/doi.org\/10.1016\/J.RDC.2019.04.008","journal-title":"Rheum Dis Clin North Am"},{"key":"8375_CR17","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.2147\/OPTH.S119872","volume":"10","author":"N Tangtavorn","year":"2016","unstructured":"Tangtavorn N, Yospaiboon Y, Ratanapakorn T et al (2016) Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients. Clin Ophthalmol 10:2179\u20132185. https:\/\/doi.org\/10.2147\/OPTH.S119872","journal-title":"Clin Ophthalmol"},{"key":"8375_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/1756-185X.12029","volume":"16","author":"P Chiowchanwisawakit","year":"2013","unstructured":"Chiowchanwisawakit P, Nilganuwong S, Srinonprasert V et al (2013) Prevalence and risk factors for chloroquine maculopathy and role of plasma chloroquine and desethylchloroquine concentrations in predicting chloroquine maculopathy. Int J Rheum Dis 16:47\u201355. https:\/\/doi.org\/10.1111\/1756-185X.12029","journal-title":"Int J Rheum Dis"},{"key":"8375_CR19","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1093\/rheumatology\/keab844","volume":"61","author":"JY Dabit","year":"2022","unstructured":"Dabit JY, Hocaoglu M, Moder KG et al (2022) Risk of hydroxychloroquine retinopathy in the community. Rheumatology (Oxford, England) 61:3172\u20133179. https:\/\/doi.org\/10.1093\/rheumatology\/keab844","journal-title":"Rheumatology (Oxford, England)"},{"key":"8375_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/J.ORET.2018.11.012","volume":"3","author":"SJ Ahn","year":"2019","unstructured":"Ahn SJ, Lee BR (2019) Hydroxychloroquine retinopathy: drug cessation versus drug continuation. Ophthalmol Retina 3:277. https:\/\/doi.org\/10.1016\/J.ORET.2018.11.012","journal-title":"Ophthalmol Retina"},{"key":"8375_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3346\/JKMS.2017.32.3.522","volume":"32","author":"DR Eo","year":"2017","unstructured":"Eo DR, Lee MG, Ham DI et al (2017) Frequency and clinical characteristics of hydroxychloroquine retinopathy in Korean patients with rheumatologic diseases. J Korean Med Sci 32:522\u2013527. https:\/\/doi.org\/10.3346\/JKMS.2017.32.3.522","journal-title":"J Korean Med Sci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08375-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:05:40Z","timestamp":1793423140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08375-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8375"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08375-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were carried out following good clinical practices in accordance with the ethical standards of the institutional committee and with the Declaration of Helsinki and its subsequent amendments or comparable ethical standards. The research protocol was approved by the Research and Ethics Committee of the Hospital Universitario \u201cDr Jos\u00e9 Eleuterio Gonz\u00e1lez\u201d Universidad Aut\u00f3noma de Nuevo Le\u00f3n on November 4, 2014 (approval Code: OF17-00014). The institutional ethics committee waived written informed consent because the risk of the study was considered less than minimal and was a standard screening procedure.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"order":3,"name":"Ethics","label":"Abstract participation in Congress","group":{"name":"EthicsHeading","label":"Declarations"}}]}}